BioSpace News Archive

Genetown

Ikena Oncology to Present at Multiple November 2023 Investor Conferences

Ikena Oncology, Inc., a targeted oncology company forging new territory in patient-directed cancer treatment, announced that management will participate in three upcoming investor conferences in November.

November 7, 2023
·
4 min read
Business

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, provided a corporate update and reported financial results for the third quarter ended September 30, 2023.

November 7, 2023
·
12 min read
Pharm Country

VYNE Therapeutics to Host Virtual R&D Day Event on November 9, 2023

VYNE Therapeutics Inc. today announced it will host a virtual R&D Day event on Thursday, November 9, 2023 at 1:30 p.m. ET.

November 7, 2023
·
4 min read
Business

Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Corbus Pharmaceuticals Holdings, Inc. today provided a corporate update and reported financial results for the third quarter of 2023.

November 7, 2023
·
11 min read
Policy

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

NeuroOne Medical Technologies Corporation announced that it has responded to the Food and Drug Administration’s questions regarding the Company’s previous submission of a 510 for its OneRF™ Ablation System.

November 7, 2023
·
5 min read
Biotech Beach

Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio

Aligos Therapeutics, Inc. today announced that the company is presenting six posters at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting® 2023, taking place in Boston, Massachusetts, November 10 – 14, 2023.

November 7, 2023
·
4 min read
Business

UroGen Pharma to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

UroGen Pharma Ltd. today announced that it will report third quarter 2023 financial results on November 14, 2023, at 8:00 AM EDT, prior to the open of the market.

November 7, 2023
·
1 min read
Biotech Bay

Nutcracker Therapeutics Demonstrates Anti-tumor Responses of Two Preclinical mRNA Drug Candidates at 2023 SITC Annual Meeting

Nutcracker Therapeutics, Inc. today presented preclinical data for two of its therapeutic candidates: its latest therapeutic candidate, NTX-471, which targets CD47; and the company’s lead mRNA candidate targeting human papillomavirus (HPV)-driven tumors, NTX-250.

November 7, 2023
·
4 min read
Drug Development

Gate Neurosciences Announces Positive Topline Human EEG Biomarker Results Demonstrating Dose-Dependent Target Activation in Phase 1 Study of Apimostinel

Gate Neurosciences, a clinical-stage biotechnology company using precision medicine approaches to develop next-generation neuroscience therapies, today announced positive topline qEEG biomarker and safety results from its Phase 1 multiple ascending dose study of apimostinel in healthy volunteers.

November 7, 2023
·
4 min read
Biotech Bay

OrsoBio Announces $60M Series A Financing to Advance Metabolic Portfolio for the Treatment of Obesity and Associated Disorders

OrsoBio, Inc. today announced the successful completion of a $60 million Series A financing, bringing the total capital raised by the Company to $97 million.

November 7, 2023
·
5 min read